524 related articles for article (PubMed ID: 17330797)
1. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
[TBL] [Abstract][Full Text] [Related]
2. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
Neaigus A; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
4. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.
Gyarmathy VA; Neaigus A; Miller M; Friedman SR; Des Jarlais DC
J Acquir Immune Defic Syndr; 2002 Aug; 30(4):448-56. PubMed ID: 12138352
[TBL] [Abstract][Full Text] [Related]
5. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
6. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
8. HIV heterosexual sexual risk from injecting drug users among HIV-seronegative noninjecting heroin users.
Neaigus A; Miller M; Gyarmathy VA; Friedman SR
Subst Use Misuse; 2011; 46(2-3):208-17. PubMed ID: 21303241
[TBL] [Abstract][Full Text] [Related]
9. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
[TBL] [Abstract][Full Text] [Related]
11. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
12. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection among noninjecting drug users in New York City.
Koblin BA; Factor SH; Wu Y; Vlahov D
J Med Virol; 2003 Jul; 70(3):387-90. PubMed ID: 12767001
[TBL] [Abstract][Full Text] [Related]
14. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
[TBL] [Abstract][Full Text] [Related]
15. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus-2 and HIV among noninjecting drug users in New York city.
Des Jarlais DC; Hagan H; Arasteh K; McKnight C; Perlman D; Friedman SR
Sex Transm Dis; 2007 Nov; 34(11):923-7. PubMed ID: 18049425
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.
de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM
Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack.
Macías J; Palacios RB; Claro E; Vargas J; Vergara S; Mira JA; Merchante N; Corzo JE; Pineda JA
Liver Int; 2008 Jul; 28(6):781-6. PubMed ID: 18312289
[TBL] [Abstract][Full Text] [Related]
19. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
20. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR; Kiely P; Keller AJ
Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
